Synapse - Sarah N. Court

Sarah N. Court

Research Focus

Former Employee. Research and Technology Management; Clinical Research Supervisor

Recent additions – View all

A phase 2 study of minimal residual disease (MRD)-adapted front line venetoclax and obinutuzumab in fit patients with chronic lymphocytic leukemia (CLL): Effect of obinutuzumab on tumor lysis syndrome (TLS) risk and safety of outpatient venetoclax dose escalation
Meeting Abstract

Roeker, L. E.; Zelenetz, A. D.; Park, J. H.; Derkach, A.; Geyer, M. B.; Islam, P.; Falchi, L.; Palomba, M. L.; Kumar, A.; Salles, G.; more...
Blood (2023)

Fulltext@MSK | Save
Outcomes of therapies and resistance mutations following non-covalent Bruton's Tyrosine Kinase inhibitor treatment for patients with chronic lymphocytic leukemia and Richter Transformation
Meeting Abstract

Thompson, M. C.; Coombs, C. C.; Roeker, L. E.; Jensen, J. L.; Shah, N. N.; Luo, T.; Patel, K.; Bailey, N.; Fakhri, B.; Eyre, T. A.; more...
Blood (2022)

Fulltext@MSK | Save

Co-authors at MSK

2

Mato
2

Palomba
2

Roeker
2

Thompson
2

Zelenetz
1

Abdel-W...
1

Aronson
1

Blesie
1

Coombs
1

Derkach
1

Falchi
1

Falco
1

Fox
1

Geyer
1

Goldberg
1

Islam
1

Kumar
1

Lebowitz
1

Lue
1

Meyer
1

Nogan
1

Panton
1

Park
1

Rao
1

Salles
1

Shah
1

Soni
1

Tyznar

Types of Work

Publications

Blood (2)